ClinicalTrials.Veeva

Menu

Platelets Indices and Its Role to Predict Liver Fibrosis in Patients With Chronic Hepatitis B Infection

A

Assiut University

Status

Not yet enrolling

Conditions

Fibrosis, Liver

Treatments

Radiation: Liver Fibroscan

Study type

Observational

Funder types

Other

Identifiers

NCT05567614
Platelets and liver fibrosis

Details and patient eligibility

About

Platelets indices and its role to predict liver Fibrosis in patients with chronic hepatitis B infection

Full description

Patients with chronic Hepatitis B infection will be collected and will do liver fibroscan to predict the degree of liver Fibrosis and correlate between the role of platelets count and degree of liver Fibrosis in patients with Chronic hepatitis B virus

Enrollment

75 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age from 18 to 70 years
  • without a history of clinical illness

Exclusion criteria

  • with other hepatitis virus infection; (b) with alcoholic liver disease; (c) with any disease related to fibrosis (such as connective tissue diseases, chronic obstructive pulmonary disease, kidney failure, tumors, and so on); (d) have received any anti-fibrosis therapy; and (e) pregnancy

Trial design

75 participants in 1 patient group

75
Description:
patients with chronic hepatitis B infection will be collected and underwill liver fibroscan then corelate between platelets indicies and predict degree of liver fibrosis
Treatment:
Radiation: Liver Fibroscan

Trial contacts and locations

1

Loading...

Central trial contact

Osama AH Ibrahim; Wafaa Ad Abdelghany, resident DR

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems